• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成肽疫苗可提供针对鼠疟的保护。

Synthetic peptide vaccine confers protection against murine malaria.

作者信息

Zavala F, Tam J P, Barr P J, Romero P J, Ley V, Nussenzweig R S, Nussenzweig V

机构信息

Department of Medical and Molecular Parasitology, New York University School of Medicine, New York 10016.

出版信息

J Exp Med. 1987 Nov 1;166(5):1591-6. doi: 10.1084/jem.166.5.1591.

DOI:10.1084/jem.166.5.1591
PMID:3316473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2189666/
Abstract

A synthetic peptide, (DPPPPNPN)2D, representing a subunit of the repeat domain of the Plasmodium berghei circumsporozoite protein, was conjugated to tetanus toxoid using bisdiazobenzidine. Immunization of mice and rats with the conjugate induced high serum titers of antibodies to the parasite, and most of the animals were completely protected from malaria infection when challenged with sporozoites.

摘要

一种合成肽(DPPPPNPN)2D,代表伯氏疟原虫环子孢子蛋白重复结构域的一个亚基,使用双偶氮联苯胺与破伤风类毒素偶联。用该偶联物免疫小鼠和大鼠可诱导产生高血清滴度的抗寄生虫抗体,并且大多数动物在用子孢子攻击时完全免受疟疾感染。

相似文献

1
Synthetic peptide vaccine confers protection against murine malaria.合成肽疫苗可提供针对鼠疟的保护。
J Exp Med. 1987 Nov 1;166(5):1591-6. doi: 10.1084/jem.166.5.1591.
2
Plasmodium berghei subunit vaccine: repeat synthetic peptide of circumsporozoite protein comprising T- and B-cell epitopes fails to confer immunity.伯氏疟原虫亚单位疫苗:包含T细胞和B细胞表位的环子孢子蛋白重复合成肽无法提供免疫保护。
Scand J Immunol. 1990 Feb;31(2):237-42. doi: 10.1111/j.1365-3083.1990.tb02764.x.
3
Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.鼠疟原虫疫苗的功效:对人类疫苗开发的启示。
Science. 1987 Apr 24;236(4800):453-6. doi: 10.1126/science.3551073.
4
Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.基于环子孢子蛋白诱导针对伯氏疟原虫感染的无菌免疫的再研究。
Vaccine. 1996 Jun;14(8):828-36. doi: 10.1016/0264-410x(95)00175-z.
5
Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei.伯氏疟原虫环子孢子蛋白的多个T辅助细胞表位
Eur J Immunol. 1988 Dec;18(12):1951-7. doi: 10.1002/eji.1830181213.
6
Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.针对鼠疟原虫约氏疟原虫环子孢子蛋白特定表位的免疫反应。
Eur J Immunol. 1990 Jun;20(6):1215-22. doi: 10.1002/eji.1830200604.
7
Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.用约氏疟原虫环子孢子蛋白多抗原肽疫苗免疫诱导保护性多克隆抗体。
J Immunol. 1995 Mar 15;154(6):2784-93.
8
Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.多抗原构建体(MACs):诱导针对啮齿类疟原虫伯氏疟原虫和约氏疟原虫子孢子阶段的无菌免疫。
Vaccine. 1997 Apr;15(5):482-8. doi: 10.1016/s0264-410x(96)00301-5.
9
Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.用于恶性疟原虫和间日疟原虫的蛋白酶体-疏水“足”疟疾肽疫苗。
Trans R Soc Trop Med Hyg. 1989;83 Suppl:101-2. doi: 10.1016/0035-9203(89)90614-7.
10
Evaluation of immunogenicity of an oral Salmonella vaccine expressing recombinant Plasmodium berghei merozoite surface protein-1.
Am J Trop Med Hyg. 1997 Feb;56(2):192-9. doi: 10.4269/ajtmh.1997.56.192.

引用本文的文献

1
Vaccines and monoclonal antibodies: new tools for malaria control.疫苗和单克隆抗体:疟疾控制的新工具。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0007123. doi: 10.1128/cmr.00071-23. Epub 2024 Apr 24.
2
Vaccination With Sporozoites: Models and Correlates of Protection.疟原虫疫苗:保护的模型和相关性。
Front Immunol. 2019 Jun 5;10:1227. doi: 10.3389/fimmu.2019.01227. eCollection 2019.
3
Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi.免疫逃逸和免疫伪装可能会降低RTS,S疫苗在马拉维的效力。
Hum Vaccin Immunother. 2020;16(2):214-227. doi: 10.1080/21645515.2018.1560772. Epub 2019 Mar 8.
4
Antibody-Mediated Protection against Sporozoites Begins at the Dermal Inoculation Site.抗体介导的对疟原虫子孢子的保护始于皮肤接种部位。
mBio. 2018 Nov 20;9(6):e02194-18. doi: 10.1128/mBio.02194-18.
5
Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective.保守结合区域为基于肽的疫苗开发提供线索:化学视角。
Molecules. 2017 Dec 12;22(12):2199. doi: 10.3390/molecules22122199.
6
What Is Known about the Immune Response Induced by Malaria Vaccine Candidates?关于疟疾候选疫苗诱导的免疫反应我们了解多少?
Front Immunol. 2017 Feb 13;8:126. doi: 10.3389/fimmu.2017.00126. eCollection 2017.
7
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.恶性疟原虫环子孢子蛋白的蛋白水解切割是保护性抗体的作用靶点。
J Infect Dis. 2015 Oct 1;212(7):1111-9. doi: 10.1093/infdis/jiv154. Epub 2015 Mar 11.
8
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.一种由荧光假单胞菌平台表达的全长恶性疟原虫重组环子孢子蛋白,作为疟疾疫苗候选物。
PLoS One. 2014 Sep 23;9(9):e107764. doi: 10.1371/journal.pone.0107764. eCollection 2014.
9
Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.一种嵌合疟原虫柏氏疟原虫株的构建,表达间日疟原虫环子孢子蛋白的重复区,用于体内评估疫苗的效力。
Infect Immun. 2013 Aug;81(8):2882-7. doi: 10.1128/IAI.00461-13. Epub 2013 May 28.
10
Calculation of the three-dimensional structures of two antigenic sequences, pro-pro-pro-pro-asn-pro-asn-asp-pro and pro-pro-pro-pro-asn-pro-asn-asp-pro-pro-pro, of the circumsporozoite protein from a malaria-causing Plasmodium.计算疟原虫环子孢子蛋白中两个抗原序列,即 pro-pro-pro-pro-asn-pro-asn-asp-pro 和 pro-pro-pro-pro-asn-pro-asn-asp-pro-pro-pro 的三维结构。
Protein J. 2013 Jan;32(1):58-67. doi: 10.1007/s10930-012-9459-9.

本文引用的文献

1
Peptides as antigens. Importance of orientation.作为抗原的肽。方向的重要性。
J Exp Med. 1986 Oct 1;164(4):1344-9. doi: 10.1084/jem.164.4.1344.
2
Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.鼠疟原虫疫苗的功效:对人类疫苗开发的启示。
Science. 1987 Apr 24;236(4800):453-6. doi: 10.1126/science.3551073.
3
Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine.间日疟原虫一种抗原在酵母中的表达,该抗原可能用于人类疟疾疫苗。
J Exp Med. 1987 Apr 1;165(4):1160-71. doi: 10.1084/jem.165.4.1160.
4
Infectivity of Plasmodium berghei sporozoites measured with a DNA probe.
Mol Biochem Parasitol. 1986 May;19(2):103-9. doi: 10.1016/0166-6851(86)90114-3.
5
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.γ-干扰素对疟原虫红细胞外期发育的抑制作用。
Science. 1986 May 16;232(4752):881-4. doi: 10.1126/science.3085218.
6
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.一种针对恶性疟原虫子孢子的合成肽疟疾疫苗在人体中的安全性和免疫原性。
Nature. 1987;328(6127):257-9. doi: 10.1038/328257a0.
7
Development of a sporozoite malaria vaccine.疟原虫子孢子疫苗的研发。
Am J Trop Med Hyg. 1986 Jul;35(4):678-88. doi: 10.4269/ajtmh.1986.35.678.
8
Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.开发针对恶性疟原虫疟疾的合成疫苗的理论依据。
Science. 1985 Jun 21;228(4706):1436-40. doi: 10.1126/science.2409595.
9
Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria.
Science. 1979 Nov 2;206(4418):597-9. doi: 10.1126/science.386511.
10
Tert-butoxycarbonylaminoacyl-4-(oxymethyl)-phenylacetamidomethyl-resin, a more acid-resistant support for solid-phase peptide synthesis.叔丁氧羰基氨基酰基-4-(氧甲基)-苯基乙酰氨基甲基树脂,一种用于固相肽合成的更耐酸的载体。
J Am Chem Soc. 1976 Nov 10;98(23):7357-62. doi: 10.1021/ja00439a041.